Clinical Trials Directory

Trials / Completed

CompletedNCT00206739

Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants

Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infant: a Randomized, Double-blind, and Placebo-controlled Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
1,070 (actual)
Sponsor
Bernhard Nocht Institute for Tropical Medicine · Other Government
Sex
All
Age
2 Months – 4 Months
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the effectiveness of Intermittent Preventive Treatment in Infants (IPTi) with Sulfadoxine-Pyrimethamine to reduce the numbers of malaria attacks, episodes of anemia, and the overall morbidity and mortality

Detailed description

In order to define the effectiveness of Intermittent Preventive Treatment in Infants (IPTi) with Sulfadoxine-Pyrimethamine, a novel principle of malaria intervention, the following parameters are evaluated: i) the level of protection from malaria attacks and episodes of anemia during the treatment period, ii) the level of protection from severe malaria during the treatment period, iii) the effect on malaria morbidity after sustaining treatment, iv) the decrease of overall morbidity and mortality, including the number of hospital admissions and visits of hospital outpatient departments v) the influence of the intervention on the development of drug resistances, vi) the impact of the intervention on the development of immunity, vii) the possible influence of the intervention on sub-clinical organ dysfunction due to chronic Plasmodium falciparum infection. Parts of the study are performed in collaboration with the Laboratory of Research, Hospital Albert Schweitzer, Lambaréné, Gabon and the School of Medicine and Health Sciences, University of Development Studies, Tamale, Ghana

Conditions

Interventions

TypeNameDescription
DRUGSulfadoxine (12.5 mg)/Pyrimethamine (250 mg)

Timeline

Start date
2003-01-01
Primary completion
2005-09-01
Completion
2005-09-01
First posted
2005-09-21
Last updated
2010-03-30

Locations

1 site across 1 country: Ghana

Source: ClinicalTrials.gov record NCT00206739. Inclusion in this directory is not an endorsement.